RIGI and melanoma: In fact, in distinct patient models we observed that activation of RIG-I by its ligand 3pRNA, a synthetic viral RNA mimetic, strongly enhanced HLA-I APM expression in melanoma cells and increased their sensitivity towards autologous CD8+ T cells.